Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Biomaterials. 2012 Aug 24;33(33):8632–8640. doi: 10.1016/j.biomaterials.2012.08.005

Table 1.

Hematologic parameters in mice treated with nanoparticles.

Treatment Hgb (g/dl) Platelets (103/mm3) WBC (103/mm3) Neutrophils (103/mm3) Lymphocytes (103/mm3)
No treatment 12.8 ± 0.6 747 ± 51 11.2 ± 0.4 1.3 ± 0.2 9.8 ± 0.3
αvβ3-Ctrl NP (1×) 13.5 ± 0.2 648 ± 14 8.8 ± 1.0 1.1 ± 0.1 7.8 ± 1.0
αvβ3-Ctrl NP (3×) 12.7 ± 0.3 698 ± 22 6.4 ± 0.4** 0.7 ± 0.1 5.6 ± 0.4**
αvβ3-Fum-PD NP (1×) 12.2 ± 0.1 738 ± 106 8.9 ± 0.5 1.7 ± 0.5 7.1 ± 0.8*
αvβ3-Fum-PD NP (3×) 13.0 ± 0.4 874 ± 52 7.3 ± 0.4** 0.9 ± 0.3 6.4 ± 0.4**
αvβ3-Fum-PD NP (3×)-24 h 13.1 ± 0.2 637 ± 10 8.9 ± 0.1 0.8 ± 0.3 7.8 ± 0.3
*

P < 0.05,

**

P < 0.001 compared with no treatment. Values obtained 30 min after the last nanoparticle injection, unless otherwise indicated. n = 12 in the no treatment group; n = 3–4 in the treated groups.